Rbf Capital, LLC Cyteir Therapeutics, Inc. Transaction History

Rbf Capital, LLC

  • $1.87 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
SELL
$1.47 - $1.84 $49,960 - $62,536
-33,987 Reduced 22.47%
117,295 $213,000
Q4 2022

Feb 14, 2023
SELL
$1.18 - $1.76 $1,298 - $1,936
-1,100 Reduced 0.72%
151,282 $249,000
Q2 2022

Aug 15, 2022
BUY
$1.62 - $4.4 $246,858 - $670,480
152,382 New
152,382 $456,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email